NFASC and myeloid sarcoma: Release of Nf from ongoing inflammation leading to axonal injury, and proteolytic breakdown of Nf isoforms, in this area is indeed a convenient model to explain high blood Nf levels in individuals with MS in absence of novel contrast‐enhancing lesions.